1940165-80-9

Boditrectinib is a potent tyrosine kinase inhibitor. Boditrectinib serves as an antineoplastic agent. Boditrectinib is useful in the research of cancer, inflammation, neurodegenerative diseases and certain infectious diseases[1][2].

[1] Kim Moonsoo, et al. Preparation of fused ring heteroaryl compounds and their use as Trk inhibitors: United States, US20160168156. 2016-06-16.
[2] WHO Drug Information-World Health Organization (WHO).